Results 131 to 140 of about 13,294 (163)
Some of the next articles are maybe not open access.
Implantable Defibrillation and Thromboembolic Events
Pacing and Clinical Electrophysiology, 1995In ICD patients thrombo‐embolic events (TEEs) are described as possible complications at implant or during the follow‐up. We report four cases of TEEs (two peripheral and two cerebral; 6.5% of patients) that occurred in our series during a mean follow‐up of 19.4 months.
G. Benedini +6 more
openaire +3 more sources
Implantation of Submammary Implantable Cardioverter Defibrillators
Pacing and Clinical Electrophysiology, 2004Implantable cardioverter defibrillators (ICDs) are routinely placed in the left pectoral area using a transvenous approach. This approach may result in poor cosmetic outcome and cause psychological problems, especially in younger patients. To avoid this, several alternative implantation techniques have been developed.
Bülent, Ozin +5 more
openaire +2 more sources
Implantable Cardioverter‐Defibrillators in Children
Pacing and Clinical Electrophysiology, 2008Implantable cardioverter‐defibrillators (ICD) in adults have shown to be safe and effective for both primary and secondary prevention of sudden cardiac death (SCD). In children and patients with congenital heart disease prospective trials to evaluate the safety and efficacy of these devices are still lacking.
openaire +2 more sources
Implantable Defibrillator Endocarditis
Pacing and Clinical Electrophysiology, 1999A B, Wagshal +6 more
openaire +2 more sources
Powering Implantable and Ingestible Electronics
Advanced Functional Materials, 2021So-Yoon Yang +2 more
exaly
1992
Early clinical reports suggested that the automatic implantable cardioverter-defibrillator (AICD) was effective in the prevention of sudden death in patients presumed to be at risk for life-threatening ventricular tachyarrhythmias [1–3]. Subsequent experience supports these impressions [4–11]. There have been no prospective studies, in which therapy is
openaire +1 more source
Early clinical reports suggested that the automatic implantable cardioverter-defibrillator (AICD) was effective in the prevention of sudden death in patients presumed to be at risk for life-threatening ventricular tachyarrhythmias [1–3]. Subsequent experience supports these impressions [4–11]. There have been no prospective studies, in which therapy is
openaire +1 more source

